Inflation Reduction Act’s cap on out-of-pocket insulin costs boosts prescription fills
The Inflation Reduction Act’s $35 cap on out-of-pocket costs for insulin has already led to increases in the total number of insulin fills for Medicare beneficiaries, according to a study from the USC Schaeffer Center for Health Policy & Economics … Read More »